As of September 30, 2026, Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs carries a market capitalization of 255.16T, placing it among publicly traded companies globally. Its enterprise value stands at 297.02T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 255.16T |
| Enterprise Value | 297.02T |
Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs's next confirmed earnings release is scheduled for January 27, 2027.
| Earnings Date | 1/27/2027 |
As of September 30, 2026, Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs has 6.40B shares outstanding.
| Shares Outstanding | 6.40B |
These figures are as of September 30, 2026.
| PB Ratio | 3.28 |
| P/TBV Ratio | -138.67 |
As of September 30, 2026, Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.45 |
| Quick Ratio | 1.00 |
| Debt / Equity | 60.36 |
These figures cover the twelve months ended September 30, 2026.
| Employee Count | 115,000.00 |
Over the twelve months ended September 30, 2026, Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs recorded 1.93T in income tax expense.
| Income Tax | 1.93T |
As of the close on November 16, 2026, Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs's stock has declined approximately 6.60% over the past 52 weeks. The 50-day moving average sits at 42,162.40, while the 200-day moving average is 39,502.70.
| 52-Week Price Change | -6.60% |
| 50-Day Moving Average | 42,162.40 |
| 200-Day Moving Average | 39,502.70 |
As of September 30, 2026, Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs holds 6.55T in cash and equivalents against 47.50T in total debt, resulting in a net debt position of 41.32T. Total book value stands at 77.79T, with working capital of 11.20T providing operational flexibility.
| Cash & Cash Equivalents | 6.55T |
| Total Debt | 47.50T |
| Net Debt | 41.32T |
| Equity (Book Value) | 77.79T |
| Book Value Per Share | 12,152.15 |
| Working Capital | 11.20T |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -2.44T |
Over the twelve months ended September 30, 2026, Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs paid dividends of 764.71 per share.
| Dividend Per Share | 764.71 |
Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs's most recent stock split took place on October 22, 2020 with a 1:2 split ratio.
| Last Split Date | 10/22/2020 |
| Split Ratio | 1:2 |